VRPharma is the first digital pharmacy with virtual reality (VR) content to reduce patients’ pain perception, fear and anxiety in the medical environment. This solution aims to improve the patient’s experience and care before, during and after medical treatments, with the objective of improving their emotional and mental health, ensuring a better recovery.
This collaboration with Bellvitge Hospital is being carried out in the Intensive Care Unit. The trial aims to assess how the use of virtual reality impacts on the levels of pain and anxiety experienced by patients during the removal of chest drains – which can take up to 48 hours after surgery – following cardiac surgery.
This is done using some of the relaxation content offered from the VRPharma library, such as Crystal Serenity and Ocean Breeze. The experience lasts between 15-20 minutes with the aim of reducing the consumption of painkillers. For this, the unit’s nurses place the VR headset on the patients and, according to their preferences, start the immersive experience from a tablet that functions as a control centre for the goggles. In this way, appropriate sanitary hygiene measures are maintained and patients are kept as comfortable as possible.
This clinical study is part of the Hospital’s various humanisation projects, whose objective, like that of VRPharma, is to improve the patient experience, providing value to their relatives, healthcare centres and healthcare staff through innovative technology.
According to the data shared by the hospital team, the experience of the first sample of patients has been very positive. The first official data from the clinical study are expected to be available in mid-2023.
For more information, contact hello@vprharma.io (Gerardo Colindres) or visit their website:
VRPharma
Pain Management, Virtual Reality, Patient Experience, patient centered care, Digital Therapeutics, prehabilitation, needle fear, pediatrics.
